Over the last few weeks, with the FDA declaring the end of the GLP-1 shortages, APC’s reporter...
In "Zepbound copycats remain online despite FDA ban," it looks at ways some compounders are continuing to dispense the drugs despite the FDA ending the shortages. APC was quote briefly about the risks they face.
Over the last few weeks, with the FDA declaring the end of the GLP-1 shortages, APC’s reporter...
Our comment to FDA about its use of the Pharmacy Compounding Advisory Committee (PCAC) was covered...
Since the FDA announced that tirzepatide is (for now) out of shortage, APC’s Scott Brunner has been...